Professional Documents
Culture Documents
ACKNOWLEDGEMENT
Acknowledgement No : 1204201902244131 Date & Time : 12/04/2019 02:24:41 PM
Scrip Code : 526783
Entity Name : DR AGARWAL'S EYE HOSPITAL LIMITED
Compliance Type : Regulation 31 - Shareholding pattern
Quarter / Period : 31/03/2019
Mode : E-Filing
General information about company
Scrip code 526783
NSE Symbol
MSEI Symbol
ISIN INE934C01018
Name of the company DR AGARWAL'S EYE HOSPITAL LIMITED
Whether company is SME No
Class of Security Equity Shares
Type of report Quarterly
Quarter Ended / Half year ended/Date of Report (For Prelisting / Allotment) 31-03-2019
Date of allotment / extinguishment (in case Capital Restructuring selected) / Listing Date
Shareholding pattern filed under Regulation 31 (1) (b)
Declaration
Sr. Promoter and Public Non Promoter-
Particular Yes/No
No. Promoter Group shareholder Non Public
1 Whether the Listed Entity has issued any partly paid up shares? No No No No
Whether the Listed Entity has issued any Convertible Securities
2 No No No No
?
3 Whether the Listed Entity has issued any Warrants ? No No No No
Whether the Listed Entity has any shares against which
4 No No No No
depository receipts are issued?
5 Whether the Listed Entity has any shares in locked-in? No No No No
Whether any shares held by promoters are pledge or otherwise
6 Yes Yes
encumbered?
Whether company has equity shares with differential voting
7 No No No No
rights?
Table I - Summary Statement holding of specified securities
Number of Voting Rights held in each
No. Of No. Of Shareholding as a % class of securities (IX)
No. of Total nos.
Category Partly shares of total no. of shares
Nos. Of fully paid shares
Category of paid-up underlying (calculated as per No of Voting (XIV)
shareholders up equity held (VII) Total as
(I) shareholder equity Depository SCRR, 1957) (VIII) Rights
(III) shares = (IV)+ a % of
(II) shares Receipts As a % of
held (IV) (V)+ (VI) Class Class (A+B+C)
held (V) (VI) (A+B+C2) Total
eg: X eg:y
Promoter
&
(A) 3 3518208 3518208 74.86 3518208 3518208 74.86
Promoter
Group
Non
(C) Promoter-
Non Public
Shares
(C1) underlying
DRs
Shares held
by
(C2)
Employee
Trusts
A Table II - Statement showing shareholding pattern of the Promoter and Promoter Group
(1) Indian
Individuals/Hindu
(a) 2 145800 145800 3.1 145800 145800 3.1
undivided Family
Any Other
(d) 1 3372408 3372408 71.75 3372408 3372408 71.75
(specify)
Sub-Total (A)
3 3518208 3518208 74.86 3518208 3518208 74.86
(1)
(2) Foreign
Total
Shareholding
of Promoter
3 3518208 3518208 74.86 3518208 3518208 74.86
and Promoter
Group (A)=
(A)(1)+(A)(2)
(3) Non-institutions
Individuals -
i.Individual
shareholders
(a(i)) 2381 660016 660016 14.04 660016 660016 14.04
holding nominal
share capital up to
Rs. 2 lakhs.
Individuals - ii.
Individual
shareholders
(a(ii)) holding nominal 8 301619 301619 6.42 301619 301619 6.42
share capital in
excess of Rs. 2
lakhs.
Any Other
(e) 88 220157 220157 4.68 220157 220157 4.68
(specify)
Sub-Total (B)
2477 1181792 1181792 25.14 1181792 1181792 25.14
(3)
Total Public
Shareholding
2477 1181792 1181792 25.14 1181792 1181792 25.14
(B)=(B)(1)+
(B)(2)+(B)(3)
C Table IV - Statement showing shareholding pattern of the Non Promoter- Non Public shareholder
Total (
2480 4700000 4700000 100 4700000 4700000 100
A+B+C2 )
Total
2480 4700000 4700000 100 4700000 4700000 100
(A+B+C )
Table II - Statement showing shareholding pattern of the Promoter and Promoter Group
Number of
Number of Shares pledged
No. Of No. Of Shares Shareholding , as a % Locked in or otherwise
No. of
Shares Underlying assuming full conversion shares (XII) encumbered Number of
Shares (XIII)
Underlying Outstanding of convertible securities ( equity shares
Underlying
Sr. Outstanding convertible as a percentage of diluted As a As a held in
Outstanding
convertible securities and share capital) (XI)= % of % of dematerialized
Warrants
securities No. Of Warrants (VII)+(X) As a % of No. total total form (XIV)
(Xi) No. (a)
(X) (Xi) (a) (A+B+C2) (a) Shares Shares
held held
(b) (b)
A Table II - Statement showing shareholding pattern of the Promoter and Promoter Group
(1) Indian
(a) 3.1 0 0 0
(d) 71.75 3372408 100 3372408
Sub-Total (A)
74.86 3372408 95.86 3372408
(1)
(2) Foreign
Total
Shareholding
of Promoter
74.86 3372408 95.86 3372408
and Promoter
Group (A)=
(A)(1)+(A)(2)
B Table III - Statement showing shareholding pattern of the Public shareholder
(1) Institutions
(3) Non-institutions
(a(i)) 14.04 526175
(a(ii)) 6.42 301619
(e) 4.68 215957
Sub-Total (B)
25.14 1043751
(3)
Total Public
Shareholding
25.14 1043751
(B)=(B)(1)+
(B)(2)+(B)(3)
C Table IV - Statement showing shareholding pattern of the Non Promoter- Non Public shareholder
Total (
100 4416159
A+B+C2 )
Total
100 3372408 71.75 4416159
(A+B+C )
Individuals/Hindu undivided Family
Searial No. 1 2
Name of the
DR SUNITA AGARWAL PANKAJ SONDHI Click here to go back
Shareholders (I)
PAN (II) AACDA7991G AEAPP4890H Total
No. of fully paid
up equity shares 145700 100 145800
held (IV)
No. Of Partly paid-
up equity shares
held (V)
No. Of shares
underlying
Depository
Receipts (VI)
No. Of Shares
Underlying
Outstanding
convertible
securities and No.
Of Warrants (Xi)
(a)
Shareholding , as a
% assuming full
conversion of
convertible
securities (as a
3.1 0 3.1
percentage of
diluted share
capital) (XI)=
(VII)+(Xi)(a) As a
% of (A+B+C2)
Name of the
DR AGARWAL'S HEALTH CARE LIMITED
Shareholders (I)
No. Of shares
underlying
Depository
Receipts (VI)
Total nos. shares
held (VII) = (IV)+ 3372408 3372408
(V)+ (VI)
Shareholding as a
% of total no. of
shares (calculated
71.75 71.75
as per SCRR,
1957) (VIII) As a
% of (A+B+C2)
No. Of Shares
Underlying
Outstanding
convertible
securities (X)
No. of Shares
Underlying
Outstanding
Warrants (Xi)
No. Of Shares
Underlying
Outstanding
convertible
securities and No.
Of Warrants (Xi)
(a)
Shareholding , as a
% assuming full
conversion of
convertible
securities (as a
71.75 71.75
percentage of
diluted share
capital) (XI)=
(VII)+(X) As a %
of (A+B+C2)
No. (a)
As a % of total
Shares held (b)
No. Of shares
underlying
Depository
Receipts (VI)
Total nos. shares
held (VII) = (IV)+ 55453 55453
(V)+ (VI)
Shareholding as a
% of total no. of
shares (calculated
1.18 1.18
as per SCRR,
1957) (VIII) As a
% of (A+B+C2)
No. Of Shares
Underlying
Outstanding
convertible
securities (X)
No. of Shares
Underlying
Outstanding
Warrants (Xi)
No. Of Shares
Underlying
Outstanding
convertible
securities and No.
Of Warrants (Xi)
(a)
Shareholding , as a
% assuming full
conversion of
convertible
securities (as a
1.18 1.18
percentage of
diluted share
capital) (XI)=
(VII)+(X) As a %
of (A+B+C2)
As a % of total
Shares held (b)
Number of equity
shares held in
55453 55453
dematerialized
form (XIV)
No. Of shares
underlying
Depository
Receipts (VI)
Total nos. shares
held (VII) = (IV)+ 201 106786 6 27966 83498 1700 106786
(V)+ (VI)
Shareholding as a
% of total no. of
shares (calculated
0 2.27 0 0.6 1.78 0.04 2.27
as per SCRR,
1957) (VIII) As a
% of (A+B+C2)
No. Of Shares
Underlying
Outstanding
convertible
securities (X)
No. of Shares
Underlying
Outstanding
Warrants (Xi)
No. Of Shares
Underlying
Outstanding
convertible
securities and No.
Of Warrants (Xi)
(a)
Shareholding , as a
% assuming full
conversion of
convertible
securities (as a
percentage of 0 2.27 0 0.6 1.78 0.04 2.27
diluted share
capital) (XI)=
(VII)+(X) As a %
of (A+B+C2)
Number of equity
shares held in
201 106786 6 27966 79298 1700 106786
dematerialized
form (XIV)
Category
Category / More
than 1 percentage
Name of the
Shareholders (I)
PAN (II) Total
No. of the
88
Shareholders (I)
Shareholding as a
% of total no. of
shares (calculated
4.69
as per SCRR,
1957) (VIII) As a
% of (A+B+C2)
Total 220157
Total as a % of
4.69
Total Voting rights
No. Of Shares
Underlying
Outstanding
convertible
securities (X)
No. of Shares
Underlying
Outstanding
Warrants (Xi)
No. Of Shares
Underlying
Outstanding
convertible
securities and No.
Of Warrants (Xi)
(a)
Shareholding , as a
% assuming full
conversion of
convertible
securities (as a
4.69
percentage of
diluted share
capital) (XI)=
(VII)+(X) As a %
of (A+B+C2)
As a % of total
Shares held (b)
Number of equity
shares held in
215957
dematerialized
form (XIV)